G Monneret Selected Research

G Monneret Research Topics

5	Sepsis (Septicemia) 01/2020 - 06/2000
4	Septic Shock (Toxic Shock Syndrome) 01/2020 - 06/2000
4	Hypersensitivity (Allergy) 01/2008 - 04/2000
2	Inflammation (Inflammations) 01/2020 - 09/2001
2	Cross Infection (Nosocomial Infection) 12/2011 - 05/2010
1	Wounds and Injuries (Trauma) 05/2010
1	Pancreatitis 05/2010
1	Critical Illness (Critically Ill) 05/2010
1	Coinfection 05/2010
1	Burns 05/2010
1	Stroke (Strokes) 05/2010
1	Chronic Urticaria 01/2008
1	Asthma (Bronchial Asthma) 09/2001
1	Bacterial Infections (Bacterial Infection) 09/2001
1	Ankylosing Spondylitis 07/2000
1	Necrosis 06/2000
1	Neoplasms (Cancer) 04/2000
1	Communicable Diseases (Infectious Diseases) 04/2000
1	Autoimmune Diseases (Autoimmune Disease) 04/2000
1	Infections 03/2000
1	Lymphoma (Lymphomas) 01/2000
1	Neutropenia 01/2000
1	Febrile Neutropenia 01/2000

2	Biomarkers (Surrogate Marker)IBA 12/2011 - 05/2010
2	HLA-DR Antigens (HLA-DR)IBA 05/2010 - 07/2003
2	LatexIBA 01/2008 - 02/2003
2	ProcalcitoninIBA 09/2001 - 03/2000
2	C-Reactive ProteinIBA 09/2001 - 03/2000
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2000 - 01/2000
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Enterotoxins (Enterotoxin)IBA 06/2008
1	Staphylococcal enterotoxin FIBA 06/2008
1	PyrazolonesIBA 01/2008
1	beta-LactamsIBA 01/2008
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2008
1	Arthropod VenomsIBA 01/2008
1	AllergensIBA 01/2008
1	Prostaglandin D2IBA 09/2001
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 09/2001
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 07/2000
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2000
1	Peptides (Polypeptides)IBA 06/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2000
1	LigandsIBA 01/2000
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2000

1	Transplantation 04/2000
1	Drug Therapy (Chemotherapy) 01/2000